About Us
Building Better Therapies for a Brighter Future
Our Values
Pioneering Tomorrow's Therapies Today
Mission
Our mission is to enhance the accessibility, reliability, and efficacy of these CGTs for patients globally, beginning with Southeast Asia.
Vision
To be a transformative force in the treatment of diseases and premature ageing in the pursuit living longer, healthier lives.
Values
To heal with compassion and scientific innovation, always guided by honesty, transparency, and urgency.
Our Team
Key Management
Sasha Omar Firdaus
Karthik Chandran
With over 15 years of experience in the biopharmaceutical industry, Karthik has led teams in designing, setting up, and operating multiple GMP laboratories for cell therapy production. His extensive experience in clinical and non-clinical product development, quality, regulations, and clinical trials, including Malaysia’s first CAR-T trial, drives our innovative and regulatory excellence.
Pratip Kumar
Our Team
Key Management
Sasha Omar Firdaus
Karthik Chandran
Pratip Chandra
Our Team
Technical Advisory Board
Clinical Pipeline
Expanded Access Policy
Celler Therapeutics is committed to developing safe and innovative cell and gene therapies to address unmet medical needs and improve patient outcomes. We recognize that there are circumstances where patients may seek access to investigational therapies outside of clinical trials, particularly when traditional treatment options have been exhausted or are unavailable. Our Expanded Access Policy (EAP) is designed to provide a pathway for patients with serious or life-threatening conditions to access investigational therapies when they meet certain criteria and in accordance with applicable regulatory requirements. EAPs are also known as Special Access Programs.
Get Started
Join us in Unravelling the Mysteries of Regenerative Medicine
Driven by the conviction that no challenge is insurmountable, we integrate innovation with compassion to shape the future of medicine by leveraging cell and gene therapies to significantly improve patient outcomes.
Driven by the conviction that no challenge is insurmountable, we integrate innovation with compassion to shape the future of medicine by leveraging cell and gene therapies to significantly improve patient outcomes.